These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1664527)

  • 21. [Drug-assisted treatment of substance dependence (Drug and Alcohol Symposium, Basel 1992)].
    Gostomzyk JG
    Gesundheitswesen; 1992 Nov; 54(11):673-7. PubMed ID: 1286251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The network of Centres for the Prevention and Treatment of Drug Addiction in the Republic of Slovenia.
    Kastelic A; Rihtar TK
    Med Arh; 2001; 55(3):135-9. PubMed ID: 11769426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 24. [Substitution treatments. Pharmacological and legislative aspects].
    Bouchez J; Khan-Shaghaghi E; Beauverie P; Poisson N
    Soins; 1997; (612):7-10. PubMed ID: 9110879
    [No Abstract]   [Full Text] [Related]  

  • 25. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an AIDS prevention education program for health service providers working with i.v. drug users.
    Nelson FL; Kabacy M
    J Subst Abuse; 1989; 1(4):467-70. PubMed ID: 2485292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients].
    Eiden C; Leglise Y; Clarivet B; Blayac JP; Peyrière H
    Therapie; 2012; 67(3):223-30. PubMed ID: 22874488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone treatment: our vision for the future.
    McCaffrey BR
    J Addict Dis; 2001; 20(1):93-101. PubMed ID: 11286435
    [No Abstract]   [Full Text] [Related]  

  • 32. [Methadone treatment of narcotic addicts--can it be defended?].
    Tidsskr Nor Laegeforen; 1991 Nov; 111(29):3552-4. PubMed ID: 1796449
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences among treatment clinic types in attitudes toward narcotic addiction.
    Nurco DN; Hanlon TE; Shaffer JW; Kinlock TW; Duszynski KR; Stephenson P
    J Nerv Ment Dis; 1988 Dec; 176(12):714-8. PubMed ID: 3199106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Program changes and retention on methadone.
    Maddux JF; Vogtsberger KN; Desmond DP; Esquivel M
    J Subst Abuse Treat; 1993; 10(6):585-8. PubMed ID: 8308944
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Politicians and scientists in the combat against drug abuse.
    Gunne LM
    Drug Alcohol Depend; 1990 Apr; 25(2):241-4. PubMed ID: 2328660
    [No Abstract]   [Full Text] [Related]  

  • 39. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
    Greenberg B; Hall DH; Sorensen JL
    J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone treatment in an intermediate care setting?
    Wayte C
    Br J Gen Pract; 2003 Oct; 53(495):808; author reply 808. PubMed ID: 14601360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.